Albert DaCosta

Global President, Foot & Ankle · Zimmer Biomet Holdings

Medical Devices

Albert DaCosta is global president of Foot & Ankle at Zimmer Biomet Holdings. He co-founded Paragon 28 and led it as president and chief executive before Zimmer Biomet acquired the company in 2025.

Last reviewed: Nov 4, 2026

Albert DaCosta

Global President, Foot & Ankle
Zimmer Biomet Holdings

Last Reviewed: November 4, 2026

Executive Summary

Albert DaCosta is global president of Foot & Ankle at Zimmer Biomet Holdings. He co-founded Paragon 28 and led it as president and chief executive before Zimmer Biomet acquired the company in 2025.

Career Highlights

  • Co-founded foot and ankle specialist Paragon 28 in 2010 and became its president and chief executive in 2012.
  • Previously held commercial roles at Linvatec, Wright Medical and medical device distribution businesses.
  • Became Zimmer Biomet’s global Foot & Ankle president following its April 2025 acquisition of Paragon 28.

Professional Journey

DaCosta’s earlier career included working as a Linvatec sales representative in 2003, serving as president of Non-Invasive Solutions in 2005 and founding Body Beautiful Laser Centers in South Florida in 2006. He also became director of Biologics and Extremities at Wright Medical and worked as a distributor for Pioneer Surgical and Biomet Sports Medicine from 2009 to 2010.

He co-founded Paragon 28 in 2010 to focus exclusively on foot and ankle surgery. He became president and chief executive in 2012 and joined its board that year. Under his leadership, the company developed from a basement start-up into a publicly traded business with an international product portfolio.

DaCosta’s professional work includes implant development and research in foot deformities. He is a named inventor on issued and pending patents and an author of peer-reviewed manuscripts. His doctoral research at the University of São Paulo uses weight-bearing CT and machine learning to classify hallux valgus and related conditions.

Zimmer Biomet completed its acquisition of Paragon 28 on April 21, 2025. DaCosta became its global president of Foot & Ankle that month, leading portfolio strategy, research and development, marketing and commercial activity.

He also serves on the University of Florida chemical engineering department’s advisory board. His entrepreneurial service includes judging the EY Entrepreneur of the Year program and chairing its Life Sciences category.

Education

DaCosta earned a BS in chemical engineering with a minor in business from the University of Florida. He is a doctoral candidate at the University of São Paulo, researching the classification of foot deformities; the doctorate is not listed as an earned degree.